company background image
4503 logo

Astellas Pharma TSE:4503 Stock Report

Last Price

JP¥1.53k

Market Cap

JP¥2.7t

7D

1.8%

1Y

-30.3%

Updated

23 Jun, 2024

Data

Company Financials +

Astellas Pharma Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Astellas Pharma
Historical stock prices
Current Share PriceJP¥1,529.50
52 Week HighJP¥2,270.00
52 Week LowJP¥1,426.00
Beta0.30
11 Month Change-2.30%
3 Month Change-7.50%
1 Year Change-30.32%
33 Year Change-23.89%
5 Year Change-0.36%
Change since IPO160.12%

Recent News & Updates

Is Astellas Pharma (TSE:4503) A Risky Investment?

Jun 14
Is Astellas Pharma (TSE:4503) A Risky Investment?

Astellas Pharma's (TSE:4503) Soft Earnings Are Actually Better Than They Appear

May 02
Astellas Pharma's (TSE:4503) Soft Earnings Are Actually Better Than They Appear

Recent updates

Is Astellas Pharma (TSE:4503) A Risky Investment?

Jun 14
Is Astellas Pharma (TSE:4503) A Risky Investment?

Astellas Pharma's (TSE:4503) Soft Earnings Are Actually Better Than They Appear

May 02
Astellas Pharma's (TSE:4503) Soft Earnings Are Actually Better Than They Appear

Astellas Pharma Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Apr 29
Astellas Pharma Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Why We're Not Concerned About Astellas Pharma Inc.'s (TSE:4503) Share Price

Feb 29
Why We're Not Concerned About Astellas Pharma Inc.'s (TSE:4503) Share Price

Shareholder Returns

4503JP PharmaceuticalsJP Market
7D1.8%0.7%-0.6%
1Y-30.3%0.3%17.8%

Return vs Industry: 4503 underperformed the JP Pharmaceuticals industry which returned 0.3% over the past year.

Return vs Market: 4503 underperformed the JP Market which returned 17.8% over the past year.

Price Volatility

Is 4503's price volatile compared to industry and market?
4503 volatility
4503 Average Weekly Movement3.7%
Pharmaceuticals Industry Average Movement3.8%
Market Average Movement3.9%
10% most volatile stocks in JP Market7.4%
10% least volatile stocks in JP Market2.1%

Stable Share Price: 4503 has not had significant price volatility in the past 3 months.

Volatility Over Time: 4503's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
192314,484Naoki Okamurawww.astellas.com

Astellas Pharma Inc. manufactures, markets, and imports and exports pharmaceuticals in Japan and internationally. The company provides XTANDI, a treatment for prostate cancer; XOSPATA, a treatment for patients who have relapsed or refractory acute myeloid leukemia with a FLT3 mutation; and PADCEV, a treatment for patients with metastatic urothelial cancer. It also offers Evrenzo, a treatment for anemia associated with chronic kidney disease; Betanis/Myrabetriq/BETMIGA, a treatment for overactive bladder; and Prograf and Advagraf/Graceptor/ASTAGRAF XL immunosuppressants.

Astellas Pharma Inc. Fundamentals Summary

How do Astellas Pharma's earnings and revenue compare to its market cap?
4503 fundamental statistics
Market capJP¥2.74t
Earnings (TTM)JP¥17.05b
Revenue (TTM)JP¥1.60t

160.9x

P/E Ratio

1.7x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
4503 income statement (TTM)
RevenueJP¥1.60t
Cost of RevenueJP¥292.49b
Gross ProfitJP¥1.31t
Other ExpensesJP¥1.29t
EarningsJP¥17.05b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)9.51
Gross Margin81.76%
Net Profit Margin1.06%
Debt/Equity Ratio57.6%

How did 4503 perform over the long term?

See historical performance and comparison

Dividends

4.8%

Current Dividend Yield

736%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.